News
04-28-2015, 06:10 PM
The European Commission has licensed Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).
More... (http://www.news-medical.net/news/20150428/First-new-treatment-authorised-in-a-decade-for-advanced-cervical-cancer-patients-in-the-UK.aspx)
More... (http://www.news-medical.net/news/20150428/First-new-treatment-authorised-in-a-decade-for-advanced-cervical-cancer-patients-in-the-UK.aspx)